share_log

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K：重大事件
美股sec公告 ·  06/27 16:09
Moomoo AI 已提取核心訊息
On June 23, 2024, Novo Integrated Sciences, Inc. amended a securities purchase agreement with Streeterville Capital, LLC. The amendment, referred to as the First Amendment, modifies the original agreement made on April 5, 2024, where Novo Integrated Sciences issued a secured convertible promissory note to Streeterville with a principal sum of $6,210,000 and a maturity date of April 8, 2025. The First Amendment allows the registration statement for at least 3,500,000 shares of common stock for Streeterville to be filed on Form S-1 or S-3 by July 3, 2024. Additionally, Streeterville waived any potential breaches or defaults by Novo Integrated Sciences related to the timely filing of the Registration Statement as of June 23, 2024. This information was disclosed in a Current Report on Form 8-K filed with the SEC, which includes the full text of the First Amendment as Exhibit 10.1.
On June 23, 2024, Novo Integrated Sciences, Inc. amended a securities purchase agreement with Streeterville Capital, LLC. The amendment, referred to as the First Amendment, modifies the original agreement made on April 5, 2024, where Novo Integrated Sciences issued a secured convertible promissory note to Streeterville with a principal sum of $6,210,000 and a maturity date of April 8, 2025. The First Amendment allows the registration statement for at least 3,500,000 shares of common stock for Streeterville to be filed on Form S-1 or S-3 by July 3, 2024. Additionally, Streeterville waived any potential breaches or defaults by Novo Integrated Sciences related to the timely filing of the Registration Statement as of June 23, 2024. This information was disclosed in a Current Report on Form 8-K filed with the SEC, which includes the full text of the First Amendment as Exhibit 10.1.
2024年6月23日，Novo Integrated Sciences公司與Streeterville Capital LLC達成了一項證券購買協議的修訂，稱爲第一修訂案，修改了2024年4月5日簽訂的原始協議，Novo Integrated Sciences向Streeterville發行了一份擔保可轉換債券，原始本金爲6,210,000美元，到期日爲2025年4月8日。第一修訂案允許Streeterville在2024年7月3日之前，以S-1或S-3表格申報至少3,500,000股普通股的註冊聲明。此外，Streeterville已經放棄了對Novo Integrated Sciences與準時提交註冊聲明有關的任何潛在違約或違約情況的權利，截至2024年6月23日。這些信息在一份提交給SEC的8-K表格的目前報告中披露，該表格包括第10.1展品的全部文本。
2024年6月23日，Novo Integrated Sciences公司與Streeterville Capital LLC達成了一項證券購買協議的修訂，稱爲第一修訂案，修改了2024年4月5日簽訂的原始協議，Novo Integrated Sciences向Streeterville發行了一份擔保可轉換債券，原始本金爲6,210,000美元，到期日爲2025年4月8日。第一修訂案允許Streeterville在2024年7月3日之前，以S-1或S-3表格申報至少3,500,000股普通股的註冊聲明。此外，Streeterville已經放棄了對Novo Integrated Sciences與準時提交註冊聲明有關的任何潛在違約或違約情況的權利，截至2024年6月23日。這些信息在一份提交給SEC的8-K表格的目前報告中披露，該表格包括第10.1展品的全部文本。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息